Skip to main content

Shah Gaurav

In the past year, 8 open-market sale filings worth $285.9K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$285.9K
8 filings
Net
−$285.9K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Shah Gaurav as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

RCKT Rocket Pharmaceuticals, Inc.

CEO20 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 20, 2026 (view filing)5:25 PM ETAug 182 daysShah GauravCEOSSale−2.29K$3.38−$7.75K−0.2%1.06M after
Aug 17, 2026 (view filing)5:52 PM ETAug 134 daysShah GauravCEOSSale−2.84K$3.38−$9.59K−0.3%1.06M after
May 26, 2026 (view filing)May 215 daysShah GauravCEOSSale−55.7K$3.09−$172.1K−5.0%1.06M after
May 21, 2026 (view filing)May 192 daysShah GauravCEOSSale−2.41K$3.01−$7.25K−0.2%1.04M after
May 14, 2026 (view filing)May 131 dayShah GauravCEOSSale−2.73K$3.61−$9.85K−0.3%1.04M after
Feb 20, 2026 (view filing)Feb 182 daysShah GauravCEOSSale−5.99K$3.34−$20.0K−0.6%1.05M after
Feb 18, 2026 (view filing)Feb 135 daysShah GauravCEOSSale−12.3K$3.31−$40.6K−1.2%1.05M after
Nov 20, 2025 (view filing)Nov 182 daysShah GauravCEOSSale−6.28K$2.98−$18.7K−0.8%778.3K after
May 22, 2025 (view filing)May 202 daysShah GauravCEOSSale−2.25K$6.45−$14.5K−0.3%786.8K after
May 20, 2025 (view filing)May 164 daysShah GauravCEOSSale−3.62K$6.53−$23.6K−0.5%789.1K after

See all 20 trades at RCKT